News
Rezzayo antifungal okayed as Candida auris rings alarm bells
Drug is first new echinocandin to be approved for marketing in the US in more than a decade.
News
FDA advisors split on Biogen’s ALS therapy
But unanimous vote on biomarker validity could support accelerated approval of tofersen.
News
Project seeks to shape digital health reimbursement in APAC
APACMed and Eversana join forces to draw up coverage frameworks applicable to APAC countries.
News
FDA rejects AbbVie’s continuous Parkinson’s therapy
Delay could narrow the gap between AbbVie's product and a rival system from Mitsubishi Tanabe.
News
Rapid UTI tests could cut antibiotic resistance, says NICE
Rapid urine tests could help NHS ensure that antibiotics are used appropriately.
Editor's Picks
Editor's Picks
